Zenas BioPharma, Inc. (ZBIO)
18.40
-0.16
(-0.86%)
USD |
NASDAQ |
May 29, 16:00
18.36
-0.04
(-0.22%)
After-Hours: 20:00
Zenas BioPharma Total Liabilities (Quarterly) : 411.85M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 274.86M |
| Gilead Sciences, Inc. | 32.85B |
| Nkarta, Inc. | 86.21M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 747.68M |
| Shareholders Equity (Quarterly) | 335.83M |
| Debt to Equity Ratio | 1.047 |
| Current Ratio | 11.94 |
| Net Debt Paydown Yield | -5.75% |